COVID-19: individual and herd immunity

被引:2
|
作者
Bach, Jean-Francois [1 ,2 ]
Berche, Patrick [1 ]
Chatenoud, Lucienne [1 ,2 ]
Costagliola, Dominique [3 ]
Valleron, Alain-Jacques [4 ]
机构
[1] Univ Paris, Paris, France
[2] Inst Necker Enfants Malad, Inserm UMR1151, UMR8253, CNRS, Paris, France
[3] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ IPLESP, INSERM, Paris, France
[4] Hosp Kremlin Bicetre, Inserm U1195, Batiment Pincus,80 Rue Gal Leclerc, F-94276 Le Kremlin Bicetre, France
关键词
SARS-CoV-2; COVID-19; Individual immunity; Herd immunity; Antibodies; T lymphocytes; CORONAVIRUS; INFECTION;
D O I
10.5802/crbiol.41
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Immunity to the SARS-CoV-2 virus ensures protection against reinfection by this virus thanks to the combined action of neutralizing antibodies and T lymphocytes specific to viral proteins, in particular the Spike protein. It must be distinguished from the immune response that ensures healing of the infection following contamination that involves innate immunity, particularly type 1 interferons, and which is followed by adaptive cellular and humoral immunity. The importance of the effect of interferons is highlighted by the occurrence of severe forms of the disease in genetically deficient subjects or in patients with antibodies neutralizing type 1 interferon. Herd immunity is not an individual biological property. It is a mathematical property that qualifies the fact that when the proportion of subjects with individual immunity is high enough, there is little chance that an epidemic can occur. The level of that proportion-the herd immunity of the population can be computed under theoretical, often unrealistic, hypotheses, and is difficult to assess in natural conditions.
引用
收藏
页码:7 / 18
页数:12
相关论文
共 50 条
  • [31] Development of Herd Immunity to COVID-19 in Louisiana Nursing Homes
    Reilly, Thomas A.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (02) : 256 - 257
  • [32] COVID-19: Cross Reactive Immunity, Herd Immunity, and Convalescent Serum Therapy
    Ibrahim, Nahla Khamis
    Bagabir, Hala Abubaker A.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (47A) : 387 - 402
  • [33] Herd Immunity to Fight Against COVID-19: A Narrative Review
    Suryawanshi, Yasha N.
    Biswas, Dalia A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [34] COVID-19 natural herd immunity and risk of neuropsychiatric disorders
    Losilla-Rodriguez, Beatriz
    Maldonado, Natalia
    Moreno-Mellado, Elisa
    Lopez-Diaz, Alvaro
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2020, 13 (04): : 228 - 229
  • [35] Caveats on COVID-19 herd immunity threshold: the Spain case
    Garcia-Garcia, David
    Morales, Enrique
    Fonfria, Eva S.
    Vigo, Isabel
    Bordehore, Cesar
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects
    Wong, Rebecca S. Y.
    MALAYSIAN JOURNAL OF PATHOLOGY, 2021, 43 (02) : 203 - 217
  • [37] Radicalizing moral conservatism in herd immunity during COVID-19
    Kahambing, Jan Gresil
    JOURNAL OF PUBLIC HEALTH, 2022, 44 (04) : E606 - E607
  • [38] COVID-19: Herd immunity and convalescent plasma transfer therapy
    Syal, Kirtimaan
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1380 - 1382
  • [39] COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
    Khalife, Jade
    VanGennep, Derrick
    EPIDEMIOLOGY AND HEALTH, 2021, 43
  • [40] Can herd immunity be relied on as a strategy to combat COVID-19?
    Virk, Amrit
    Samdarshi, Narottam
    INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES, 2020, 9 : 73 - 76